The Hon Jillian Skinner, NSW Minister for Health and Minister for Medical Research joined APGI researchers, Garvan Institute of Medical Research colleagues, pancreatic cancer patients and their family members at Parliament House in Sydney recently to officially launch the month of November 2013 as Pancreatic Cancer Awareness month. At the conclusion of the formal proceedings a large cake in the shape of a purple ribbon was cut and guests enjoyed the opportunity to chat with one another over morning tea. We have heard some truly moving and extraordinary stories over the months from patients and their carers, one in particular we would like to share with you here. From Erica, who warmly addressed the Minister and audience at last week’s Parliament House event with an insightful speech on her roller coaster journey.
The 4th Annual APGI Meeting was held on Saturday 11 May 2013 and we were truly delighted that so many of you were able to attend. It was a very successful meeting with approximately 150 Registrants and the feedback we have received has been extremely positive, not only from the scientists and medical health professionals that were present, but equally important from our community members, their families and friends.
"Pancreatic cancer is not one disease, but many, and suggests that people who seemingly have the same cancer might need to be treated differently" said Professor Andrew Biankin as he discussed the APGI's findings published in Nature. This is set to change the face of treatment, moving towards the vision of personalised medicine which matches the right treatment to the right individual.
APGI researchers at the Garvan Institute were awarded the Cancer Institute NSW Inaugural Wildfire Award 2012. This prestigious award recognises research which has had a lasting impact on the cancer field.
November is International Pancreatic Cancer Awareness Month. Please join us in raising much needed awareness for this devastating disease. You can participate in one of our scheduled events, arrange your own or simply make a donation. Everything helps!
The APGI contributed to this study and co-authors this Nature Publication. We’re now seeing some real movement in the field of pancreatic cancer research, and the APGI has been at the heart of much of this work.
Sean Grimmond presents at sequencing seminar during Advances in Genome Biology and Technology Meeting.
There is a need to to develop biological markers (biomarkers) to better group pancreatic cancer sufferers for treatment types and for testing individual treatment strategies. A Sydney gastroenterologist, Dr Humphris who is part of the APGI research team has brought new insight to this battle with his work on CA19.9.